Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /CNW/ — Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing…
Browsing Tag